Insmed (INSM) Share-based Compensation (2010 - 2026)

Insmed's Share-based Compensation history runs 17 years deep, the most recent figure standing at $45.8 million for Q1 2026.

• In Q1 2026, Share-based Compensation rose 16.54% year-over-year to $45.8 million; the TTM figure through Mar 2026 stood at $159.2 million (up 38.86% YoY), while the FY2025 annual figure was $152.7 million, up 57.7% from the prior year.
• Share-based Compensation was $45.8 million for Q1 2026 at Insmed, up from $39.0 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $45.8 million in Q1 2026 to a low of $12.8 million in Q1 2022.
• Historically, Share-based Compensation has averaged $25.2 million across 5 years, with a median of $21.4 million in 2024.
• The sharpest annual moves came in 2025 and 2026: Share-based Compensation soared 84.56% in 2025, then advanced 16.54% in 2026.
• A 5-year view of Share-based Compensation shows it stood at $15.0 million in 2022, then surged by 33.67% to $20.0 million in 2023, then soared by 32.88% to $26.6 million in 2024, then surged by 47.02% to $39.0 million in 2025, then gained by 17.2% to $45.8 million in 2026.
• The last three Share-based Compensation figures came in at $45.8 million (Q1 2026), $39.0 million (Q4 2025), and $31.4 million (Q3 2025), per Business Quant data.